BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 25253512)

  • 21. Gene Regulatory Network Analysis Identifies Sex-Linked Differences in Colon Cancer Drug Metabolism.
    Lopes-Ramos CM; Kuijjer ML; Ogino S; Fuchs CS; DeMeo DL; Glass K; Quackenbush J
    Cancer Res; 2018 Oct; 78(19):5538-5547. PubMed ID: 30275053
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Claudin-7 indirectly regulates the integrin/FAK signaling pathway in human colon cancer tissue.
    Ding L; Wang L; Sui L; Zhao H; Xu X; Li T; Wang X; Li W; Zhou P; Kong L
    J Hum Genet; 2016 Aug; 61(8):711-20. PubMed ID: 27121327
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene expression signatures for HOXA4, HOXA9, and HOXD10 reveal alterations in transcriptional regulatory networks in colon cancer.
    Bhatlekar S; Ertel A; Gonye GE; Fields JZ; Boman BM
    J Cell Physiol; 2019 Aug; 234(8):13042-13056. PubMed ID: 30552679
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene expression and methylation profiles identified CXCL3 and CXCL8 as key genes for diagnosis and prognosis of colon adenocarcinoma.
    Zhao QQ; Jiang C; Gao Q; Zhang YY; Wang G; Chen XP; Wu SB; Tang J
    J Cell Physiol; 2020 May; 235(5):4902-4912. PubMed ID: 31709538
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RNA-seq based transcriptomic map reveals new insights into mouse salivary gland development and maturation.
    Gluck C; Min S; Oyelakin A; Smalley K; Sinha S; Romano RA
    BMC Genomics; 2016 Nov; 17(1):923. PubMed ID: 27852218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Colon cancer recurrence‑associated genes revealed by WGCNA co‑expression network analysis.
    Zhai X; Xue Q; Liu Q; Guo Y; Chen Z
    Mol Med Rep; 2017 Nov; 16(5):6499-6505. PubMed ID: 28901407
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Network-based identification of key master regulators associated with an immune-silent cancer phenotype.
    Mall R; Saad M; Roelands J; Rinchai D; Kunji K; Almeer H; Hendrickx W; M Marincola F; Ceccarelli M; Bedognetti D
    Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 33979427
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epigenomic enhancer profiling defines a signature of colon cancer.
    Akhtar-Zaidi B; Cowper-Sal-lari R; Corradin O; Saiakhova A; Bartels CF; Balasubramanian D; Myeroff L; Lutterbaugh J; Jarrar A; Kalady MF; Willis J; Moore JH; Tesar PJ; Laframboise T; Markowitz S; Lupien M; Scacheri PC
    Science; 2012 May; 336(6082):736-9. PubMed ID: 22499810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microenvironment dependent gene expression signatures in reprogrammed human colon normal and cancer cell lines.
    Strainiene E; Binkis M; Urnikyte S; Stankevicius V; Sasnauskiene A; Kundrotas G; Kazlauskas A; Suziedelis K
    BMC Cancer; 2018 Feb; 18(1):222. PubMed ID: 29482503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lower connectivity of tumor coexpression networks is not specific to cancer.
    Dalgıç E; Konu Ö; Öz ZS; Chan C
    In Silico Biol; 2019; 13(1-2):41-53. PubMed ID: 31156157
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integrative genomic approaches to dissect clinically-significant relationships between the VDR cistrome and gene expression in primary colon cancer.
    Long MD; Campbell MJ
    J Steroid Biochem Mol Biol; 2017 Oct; 173():130-138. PubMed ID: 28027912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distinct and competitive regulatory patterns of tumor suppressor genes and oncogenes in ovarian cancer.
    Zhao M; Sun J; Zhao Z
    PLoS One; 2012; 7(8):e44175. PubMed ID: 22952919
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of hub subnetwork based on topological features of genes in breast cancer.
    Zhuang DY; Jiang L; He QQ; Zhou P; Yue T
    Int J Mol Med; 2015 Mar; 35(3):664-74. PubMed ID: 25573623
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
    Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
    Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification prognosis-associated immune genes in colon adenocarcinoma.
    Miao Y; Wang J; Ma X; Yang Y; Mi D
    Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33140821
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel miRNAs as potential biomarkers in stage II colon cancer: microarray analysis.
    Gungormez C; Gumushan Aktas H; Dilsiz N; Borazan E
    Mol Biol Rep; 2019 Aug; 46(4):4175-4183. PubMed ID: 31123908
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic network topology reveals transcriptional regulatory signatures of type 2 diabetes.
    Zelezniak A; Pers TH; Soares S; Patti ME; Patil KR
    PLoS Comput Biol; 2010 Apr; 6(4):e1000729. PubMed ID: 20369014
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estrogen receptor β induces antiinflammatory and antitumorigenic networks in colon cancer cells.
    Edvardsson K; Ström A; Jonsson P; Gustafsson JÅ; Williams C
    Mol Endocrinol; 2011 Jun; 25(6):969-79. PubMed ID: 21493669
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Integrated analysis of gene expression signatures associated with colon cancer from three datasets.
    Gao P; He M; Zhang C; Geng C
    Gene; 2018 May; 654():95-102. PubMed ID: 29408621
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systematic identification of transcriptional and post-transcriptional regulations in human respiratory epithelial cells during influenza A virus infection.
    Liu ZP; Wu H; Zhu J; Miao H
    BMC Bioinformatics; 2014 Oct; 15(1):336. PubMed ID: 25281301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.